1,759 results on '"Rammensee, Hans-Georg"'
Search Results
2. Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency
3. DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts
4. Advances in PET imaging of cancer
5. A T-cell antigen atlas for meningioma: novel options for immunotherapy
6. Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma
7. The HLA ligandome of oropharyngeal squamous cell carcinomas reveals shared tumour-exclusive peptides for semi-personalised vaccination
8. Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults
9. Validation of HLA presented tumor-exclusive peptides in an independent cohort of head and neck squamous cell carcinoma.
10. Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade
11. Immunocytokines with target cell–restricted IL-15 activity for treatment of B cell malignancies
12. The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
13. Radiotherapy planning parameters correlate with changes in the peripheral immune status of patients undergoing curative radiotherapy for localized prostate cancer
14. Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma* [S]
15. A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
16. Identification of tumor antigens for T-cell-mediated cancer immunotherapy
17. List of contributors
18. Identification and relative abundance of naturally presented and cross-reactive influenza A virus MHC class I-restricted T cell epitopes
19. Upstream open reading frames regulate translation of cancer-associated transcripts and encode HLA-presented immunogenic tumor antigens
20. Tumorimmunologie: Die neue vierte Säule der Tumortherapie
21. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
22. Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
23. 1463 The intra-tumoral spatial heterogeneity of T cell antigens in glioblastoma: An integrated multi-omics approach
24. Supplementary Figures S1-S13 from Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells
25. Data from Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells
26. Supplementary Tables S1 to S15 from Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells
27. 872 Combined multi-omics analysis delineates the impact of epigenetic therapies on the immunopeptidome of acute myeloid leukemia
28. Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells
29. Individualisierte Immuntherapie von Tumorerkrankungen mittels Peptidimpfstoffen – Funktioniert das vielleicht doch?
30. Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire
31. Combining alpha radiation-based brachytherapy with immunomodulators promotes complete tumor regression in mice via tumor-specific long-term immune response
32. The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy
33. P480: DNMT AND HDAC INHIBITION INDUCES IMMUNOGENIC NEOANTIGENS FROM HUMAN ENDOGENOUS RETROVIRAL ELEMENT-DERIVED TRANSCRIPTS
34. Immunoprecipitation methods impact the peptide repertoire in immunopeptidomics
35. Activated integrins identify functional antigen-specific CD8⁺ T cells within minutes after antigen stimulation
36. The immunopeptidomic landscape of ovarian carcinomas
37. Contribution of the plasma and lymph Degradome and Peptidome to the MHC Ligandome
38. Actively personalized vaccination trial for newly diagnosed glioblastoma
39. Personalized cancer vaccines: adjuvants are important, too
40. Glycoprotein 96-Activated Dendritic Cells Induce a CD8-Biased T Cell Response
41. Autophagy Promotes MHC Class II Presentation of Peptides from Intracellular Source Proteins
42. A novel multi-antigenic parapoxvirus-based vaccine demonstrates efficacy in protecting hamsters and non-human primates against SARS-CoV-2 challenge
43. Supplementary Data from PD-1 and LAG-3 Dominate Checkpoint Receptor–Mediated T-cell Inhibition in Renal Cell Carcinoma
44. Data from PD-1 and LAG-3 Dominate Checkpoint Receptor–Mediated T-cell Inhibition in Renal Cell Carcinoma
45. Supplementary Table 1 from Alternative Variants of Human HYDIN Are Novel Cancer-Associated Antigens Recognized by Adaptive Immunity
46. Supplementary Table 3 from Alternative Variants of Human HYDIN Are Novel Cancer-Associated Antigens Recognized by Adaptive Immunity
47. Supplementary Figure 1 from Alternative Variants of Human HYDIN Are Novel Cancer-Associated Antigens Recognized by Adaptive Immunity
48. Figures S1-S5 and Tables S1-S3 from Preexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
49. Data from Alternative Variants of Human HYDIN Are Novel Cancer-Associated Antigens Recognized by Adaptive Immunity
50. Data from Preexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.